BA Sciences has the expertise and capabilities needed to create non-compendial pharmaceutical raw materials testing when those materials do not fit easily into existing pharmacopeia. We follow a structured process for developing these tests that typically looks like this:
- Method Design: Our scientists evaluate the raw material’s chemical, physical, and biological properties to determine the most appropriate analytical testing approach.
- Method Optimization: We refine sample preparation, extraction procedures, detection sensitivity, and analytical parameters to ensure the method is suitable for its intended purpose.
- Method Validation: Our team evaluates method performance against established acceptance criteria, following applicable regulatory guidance, including ICH Q2(R2), with consideration of ICH Q14 principles for analytical procedure development.
- Lifecycle Monitoring: As testing requirements, formulations, or manufacturing processes evolve, BA Sciences can reassess method performance and implement adjustments to maintain reliable analytical results.
